January 18, 2012

Genzyme Announces European Approval of Framingham Manufacturing Plant

 

Genzyme Announces European Approval of Framingham Manufacturing Plant

Paris, France – January 18, 2012 – Sanofi (EURONEXT: SAN and NYSE: SNY) and its subsidiary Genzyme announced today that the European Medicines Agency (EMA) has approved its manufacturing plant in Framingham, Mass., for the production of Fabrazyme® (agalsidase beta).